Anti-Human EPHA3 Therapeutic Antibody (Ifabotuzumab)

Recombinant monoclonal antibody to EPHA3. Ifabotuzumab is a humanized monoclonal antibody that can be potentially used in the treatment of Myelodysplastic syndrome, Myelofibrosis, Cancer.
Supplier Creative Biolabs
Product # TAB-430CQ
Pricing Inquiry
Host Human
Target EPHA3
Species Reactivity Human
Type IgG1, κ
Applications Used for immunoassay techniques such as: Enzyme-Linked Immunosorbent Assay; Immunohistochemistry; Immunofluorescence; Immunoprecipitation; Flow Cytometry; Functional Studies
Storage Store at -20°C for long-term storage. Avoid freeze/thaw cycles.
Feedback